X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Tata Chemicals: Investment income saves bottomline - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Jun 2, 2000

    Tata Chemicals: Investment income saves bottomline

    A 35% decline in the net profit despite over 1173 m of income accruing from the sale of investments tells the story of the year gone by for Tata Chemicals.

    Though dumping from China affected the margins in soda ash, the fact remains that the lack of growth in the industrial production led to the over capacity situation persisting in the industry. Margins would only improve once the industry utilises the full capacity set up. The absence of big buyers such as Nirma who have backward integrated into soda ash has further exacerbated the situation.

    (Rs m) FY99 FY00 Change
    Sales 14,641 15,210 3.9%
    Other Income 361 1,393 285.4%
    Expenditure 9,717 10,845 11.6%
    Operating Profit (EBDIT) 4,924 4,365 -11.4%
    Operating Profit Margin (%) 33.6% 28.7%  
    Interest 1,945 1,857 -4.5%
    Depreciation 1,162 1,235 6.3%
    Profit before Tax 2,179 2,667 22.4%
    Other Adjustments (82) (1,236)  
    Tax 282 262 -7.1%
    Profit after Tax/(Loss) 1,816 1,170 -35.6%
    Net profit margin (%) 12.4% 7.7%  
    Earnings per share 10.05 6.49  

    As far as the fertliser division though sales and profit are stated to be higher than those achieved last year, the fact remains that the fertliser companies such as Tata Chemicals book sales at retention prices and the difference between the retention prices and selling prices is shown as dues receivable from the government. During the last year the government notified the retention price for 1994-95 and 1995-96 and since the notified price was lower than what the company had booked in its turnover for those years, the company had to provide for Rs 800 m as a contingency provision. In the current year, Tata Chemicals has already provided for contingencies amounting to Rs 1200 m from the current year's profit. This infact is more than the net profit for the year and actually seems to be a provision for any shortfall in the notified retention price and the selling price for the previous two years.

    The stock however seems to have factored these developments. Tata Chemicals quotes at Rs 41, which implies an earning multiple of 6.3x the FY2000 earnings.

     

     

    Equitymaster requests your view! Post a comment on "Tata Chemicals: Investment income saves bottomline". Click here!

      
     

    More Views on News

    Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

    Aug 17, 2017

    Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

    Tata Chemicals: Lower Finance Costs Boost Profits (Quarterly Results Update - Detailed)

    Jun 2, 2017

    Tata Chemicals registers 54.2% YoY rise in net profits during fourth quarter of FY17 on the back of lower finance costs and rise in other income.

    Tata Chemicals: Urea division dampens performance (Quarterly Results Update - Detailed)

    Nov 18, 2016

    Tata Chemicals has reported consolidated topline fall of 17% YoY while the bottomline has fallen 5% YoY

    Tata Chemicals: Operating margins catalyze strong profit growth (Quarterly Results Update - Detailed)

    Aug 18, 2016

    Tata Chemicals has reported consolidated topline fall of 9% YoY while the bottomline has grown 40% YoY.

    Tata Chemicals: Ends the year on a good note (Quarterly Results Update - Detailed)

    Jun 8, 2016

    Tata Chemicals reported consolidated topline growth of 7% YoY while the bottom line stood at Rs 2.4 bn as opposed to a loss during same quarter last year.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    TATA CHEMICALS SHARE PRICE


    Aug 17, 2017 (Close)

    TRACK TATA CHEMICALS

    • Track your investment in TATA CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks

    MORE ON TATA CHEMICALS

    TATA CHEMICALS 5-YR ANALYSIS

    Detailed Financial Information With Charts

    COMPARE TATA CHEMICALS WITH

    MARKET STATS